A precompetitive initiative working towards the implementation of new solutions to prevent bacterial diseases and reduce the use of antibiotics has been announced in Chile.
A clinical trial evaluating two different immunisation schedules for a new COVID-19 vaccine shows that both regimens generate a similar immune response, according to results published in <i>eLife</i>.
Researchers evaluating the CoronaVac SARS-CoV-2 vaccine in patients find that spacing vaccine doses two- or four- weeks apart results in similar immunity.
The CoronaVac vaccine is safe and effective against Covid19 and its variants, including Delta and Omicron. This is the main and encouraging conclusion of a scientific study that was led by the Pontifical Catholic University of Chile and the Millenniu
More than two years into the pandemic, most countries are striving to live alongside COVID-19, accepting the virus as part of everyday life. China, where the pathogen first emerged, exists in an alternate reality, wedded to a zero-tolerance strategy that is growing harder to maintain.
Despite firmly closed borders and a vaccination rate near 90 percent, the highly transmissible Omicron variant of SARS-CoV-2 has been reported in seven out of 31 provinces and all of China’s major cities. Port disruptions and citywide shutdowns are increasingly common, and the government on Monday signaled that it is bracing for more. The central bank